Clinical outcomes and protocol for the management of isolated congenital diaphragmatic hernia based on our prenatal

Kazunori Masahata1, Noriaki Usui1, Yoshiyuki Shimizu2

  • 1Department of Pediatric Surgery, Osaka Women's and Children's Hospital, Izumi, Japan.

Insights

This study validated a prenatal risk stratification system for isolated congenital diaphragmatic hernia (CDH), showing significant differences in outcomes based on risk groups. The system aids in risk-adjusted management for fetuses with CDH.

Area of Science:

  • Fetal Medicine
  • Pediatric Surgery
  • Neonatology

Background:

  • Congenital diaphragmatic hernia (CDH) is a serious condition requiring accurate risk assessment.
  • Prenatal diagnosis and risk stratification are crucial for optimizing management strategies.

Purpose of the Study:

  • To evaluate a prenatal risk stratification system for isolated congenital diaphragmatic hernia (CDH).
  • To assess the system's utility in risk-adjusted management of fetuses with CDH.

Main Methods:

  • Retrospective single-center cohort study of 94 infants with isolated CDH.
  • Prenatal classification into four risk groups (A, B, C) based on liver position and lung-to-thorax ratio (L/T).
  • Analysis of survival and intact discharge rates across risk groups.

Main Results:

  • Group A (no liver-up, L/T >0.08) had 100% survival; subgroups A-1 (mild) and A-2 (severe) had 91.7% and 90.0% intact discharge, respectively.
  • Group B (liver-up or L/T <0.08) had 87.0% survival and 52.1% intact discharge.
  • Group C (liver-up and L/T <0.08) had 58.8% survival and 23.5% intact discharge.

Conclusions:

  • The prenatal risk stratification system effectively differentiates disease severity in isolated CDH.
  • The system demonstrates significant differences in postnatal status and clinical outcomes among risk groups.
  • This tool supports risk-adjusted management for fetuses diagnosed with CDH.
Abstract

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
319
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
198
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
227